To date, the production of T-even bacteriophage with giant heads has been achieved in two ways: (i) by use of canavanine-arginine treatment of Escherichia coli B cultures infected by wild-type bacteriophage (Cummings and Bolin, Bacteriol. Rev. 40:314-359, 1976; Cummings et al., Virology 54:245-261, 1973 1976). We now report the effect of mixed infection with several mutants of T4D on both the production and the size of giant bacteriophage. We found that gene 24 mutant is a critical partner for the production of giants. Infection using T4.24 mutants together with either T4.23 mutants, T4B+ or T6+ led to the formation of giants with heads 10-to 14-fold longer than normal-length heads. Infection with amber 24-bypass 24 double mutants of T4D led to the production of giants when gene 23 mutant was used to co-infect. Addition of canavanine to the co-infected cultures could alter the size distribution of giants, depending on which phage were used to co-infect. Gene 22 mutants had a modifying effect on these results. In the absence of canavanine coinfection with gene 22 mutants prevented the production of giants, and in the presence of canavanine giants of 1.5 to 5 head lengths were found. We have interpreted these results to mean that critical concentrations of gene products 22, 23, and 24 interact to control head length in T-even bacteriophage.
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One of the most important problems in T4 bacteriophage morphogenesis is the mechanism of head length determination. Although many gene products have been identified and their role in maturation assessed (15, 19, 22) , no single gene has been directly credited with control of head length. Several years ago, Eiserling et al. (14) reported the isolation of a mutant in gene 66 that yielded mostly short-headed variants in addition to virions with normal-length heads. Further study has revealed (13) that this mutation is actually in gene 23, which codes for the major head protein (13, 26) . In the course of their study, Doermann et al. (12, 13) isolated point mutations in gene 23 that gave rise to giant bacteriophage, i.e., virions with heads longer than normal length. At about the same time, Cummings et al. (9) found that inhibition of a wild-type T-even bacteriophage-infected culture with canavanine, followed by the release of inhibition with arginine, also led to the production of giants. These canavanine-induced giants were termed "lollipops," and subsequent studies (2, 8) have shown them to be identical with the giants formed by the missense mutants in gene 23 (12, 13) . Further, Aebi et al. (1) found that certain temperaturesensitive (ts) mutants in gene 24 also gave rise to giants, along with mainly normal phage, when grown at temperatures intermediate between the restrictive and permissive temperatures. Although the mechanism for the formation of giants is still unclear, it is clear that the discovery of giants, along with the previously reported existence of small-headed variants (petites), has provided a basis for the study of head length control.
The lack of conditionally lethal mutants that lead to giant or petite phage should not be surprising. For some years (7, 10, 11) we have been able to interfere with head assembly by using amino acid analogues and have suggested (11) that protein subunit interactions were the critical factors in head assembly. Based on the production of giants by certain mutants (1, 12, 13) , an interaction between p23 and p24 has been implicated (1, 2, 8) . With regard to other possible gene product involve-CUMMINGS, CHAPMAN, AND DzLONG ment, p22 may be a possibility. Along with the internal protein, p22 forms the so-called "core" material that is considered to be essential for the initiation of head formation (21, 28) . Laemmli and his collaborators (22, 25) have proposed that this core material has a structural repeat unit that interacts with the putative structural repeat unit of the capsid proteins such that when the two structural repeats are in register, then the length of the head is determined. This Vernier-type mechanism has been recently reviewed and discussed at length (8) .
To explore the possibility of specific gene product interactions, we elected to study the effect of mixed infections on the production of giants, with or without canavanine-arginine treatment (9) . With this approach, we could examine both the production of giants and the factors that influenced their length. Earlier, we found (8, 9) that the length distribution of canavanine-induced giants was phage specific. This is illustrated in Fig. 1 (20, 21, 22, 23, 24, 31 , and 40) are involved in the early steps of head formation and cleavage (19) and the group B genes (2, 4, 13, 14, 16, 17, 49, 50, 64 , and 65) control the late steps of head maturation. We will present evidence that of the group A genes, only co-infection with gene 23 and 24 mutants led to the formation of giants. Of the group B genes we tested two, and both yielded giants when coinfected with a gene 24 mutant. All these giants were of the 10 to 14 size class. Gene 22 mutants had a modifying effect. In the absence of canavanine, co-infection with gene 22 mutants prevented the formation of giants, whereas in the presence of canavanine, giants of 1.5 to 5 head lengths were observed. These as well as other types of mixed-infection data will be presented and discussed.
MATERIALS AND METHODS Bacteria and growth conditions. Escherichia coli B was used in all the mixed infections reported here. Except where indicated, all the infections were carried out at 390C in a minimal salts medium supplemented with amino acids (7), bubbling vigorously with oxygen. The cells were infected with a multiplicity of infection of 5 for each phage in the mixed infection. Occasionally the culture was superinfected at 10 min with the same amount of phage, but no differences were noted in the absence of superinfection. Where appropriate, L-canavanine sulfate was added to 130 ,g/ml at 11 min followed by the same amount of L-arginine at 27 min (9) . After 150 min, infection was stopped by the addition of chloroform; lysozyme to 400 ,ug/ml was added to assist lysis, and the culture was stored at 4°C overnight. The lysates were concentrated directly, without lowspeed centrifugation to remove debris, by centrifugation at 14,000 rpm for 2 h in an IEC-B20 centrifuge. The pellets were resuspended in buffer consisting of 0.25 M NaCl, 5 mM sodium azide, 4 mM sodium phosphate, 2 mM MgSO4, pH 7, and examined in the electron microscope.
Stocks of amber mutants were grown on the premissive host CR63 as described previously (9) . Titers of the mutant stocks were about 1,000-fold greater under permissive conditions than under restriction conditions. Phage resulting from the mixed infections assayed only about 10-fold greater on CR63.
Bacteriophage Electron microscopy. Electron microscopy using phosphotungstic acid negative staining (4) was performed as described previously (9) . Measurements of the lengths of the giant heads were done directly on the fluorescent screen of the RCA 4A EMU, using normal phage in the same field as comparison. All the giants in one grid opening were scored along with the numbers of normal and petite phage. Only the normal and petite phage containing DNA were used for calculating the percentage of giants. 
RESULTS
Production of giants in the absence of canavanine. Previously, we reported (8) that mixed infections with mutant bacteriophage yielded giants only when a gene 24 mutant was one of the infecting phage. We want now to explore this result in more detail, particularly from the viewpoint of whether this effect is gene specific or whether only certain mutants of that gene will lead to giants. In Table 1 are listed the results using four mutants each of gene 24 and gene 23. As can be noted, all pairings yielded giants, some more than others. For example, 24(amN65) + 23(amE506) yielded 0.259% (by number) giants, whereas 24(amE303) + 23(amB17) gave only 0.006%. These percentages are about 10-fold less than that obtained with T4D using canavanine-arginine treatment (9) , and the percentages of giants in these mixed infections were increased when canavanine-arginine treatment was used. The size distribution of giants formed in these mixed infections was uniformly 10 to 14 head lengths. A typical distribution pattern can be seen in Fig.  2A . Quantitatively, different mutants within the same gene gave different amounts of giant, suggesting perhaps that gene product interaction depended on the size of the gene product fragment generated. Nevertheless, it is clear that qualitatively the actual production of giants was gene specific and did not depend on a particular mutation of that gene. This confirms the suggestion (2) that the effect is gene specific for the ts mutants of gene 24 even though those mutants were not intragenically mapped. Gene 23 has been mapped extensively (13, 26) , and although the map of gene 24 is not fully elaborated, all the mutants used here are distinct. Also shown in Table 1 (1, 3, 20, 21) . Moreover, p24* (the cleavage product of p24) is a component of the phage head (19 We examined the effect of mixed infections and canavanine-arginine treatment on the production of giants (Table 2 ). In the absence of canavanine, some giants were found when 24-was the co-infecting phage, and this percentage was increased when canavanine-arginine treatment was used. As expected, a fair number of petite phage were scored. It is possible that the reduced number of petites found when 23 Table 4 with the effect of gene 22 on head length, but is presented here for comparison.
In the restrictive host, E. coli B, infection by the double mutant 24--bypass 24 leads to the production of viable phage at 41'C but at 25 to 30'C there is an accumulation of T particles and polyheads (Black et al., personal communication). The viable phage produced at 41'C lack p24*, a protein previously thought to be an essential component of phage heads. We examined the effect of two such mutants, (amE303) bypass 24 and (amN65) bypass 24, on the production of giants (Table 3) . Alone or with either 22-, (21,22)-, or 24-co-infections, (amE303) bypass 24 did not lead to the formation of giants. Even in the presence of canavanine, 24-coinfections did not assist in the production of giants. However, for both (amE303) bypass 24 and (amN65) bypass 24, co-infection with any of four 23-mutants yielded giants, all of which were in the 10 to 14 size class. Chronologically, these experiments were done initially with (amE303) bypass 24 and 23(amB17) co-infection, and there we found that addition of canavanine-arginine reduced the number of giants. However, additional pairings showed that this did not occur uniformly. As with the (amE303) bypass 24, co-infection of 23(amB17) with (amN65) bypass 24 gave this effect, as did (amE303) bypass 24 and 23(amE1236), but in all other pairings, canavanine-arginine treatment led to an increase in the number of giants. In general, the giants made in the absence of canavanine were in the 10 to 14 size class (Fig. 3A) , but addition of canavanine led either to a broad size range (Fig. 3B) or to varying proportions of a diphasic distribution.
The simplest interpretation of these results is that the altered p23 synthesized by the 24--bypass 24 mutants interacts with the p24 product generated by the four 23-mutants to promote the formation of giants, but that the degree of interaction or the control of that interaction varies. In one pairing, the percentage of giants in the presence or absence of canavanine was little reduced from that with wild type, 0.4% versus 1.2%. The map location of the gene 23 mutants on gene 23 ranges from the cleavage region (N-terminal portion) all the way to the C-terminal region (13) , but the positions for the gene 24 mutants are not yet known. That it is the presence of the altered p23 which is involved here is suggested by the fact that growth at a restrictive temperature, 30°C, eliminated the production of giants even though wild-type phage with canavanine-arginine treatment produced about 0.5%. The 2-to 6-head-length size class of the giants produced by wild-type at 39°C may indicate that temperature can affect gene product interactions in the presence of canavanine as it presumably does for the ts gene 24 mutants (1, 2) .
Role of gene 22 product on giant size. Gene product 22 has been implicated as an essential factor in determining head length (22, 25) . Interspersed throughout this report is the effect of 22-mutants on the size of giant heads. We examined the effect of 22-mutants on the production of giants in two ways: (i) in the absence of canavanine, and (ii) with canavanine-arginine treatment (Table 4) . Because of the low phage yields of single mutants of gene 22 in our hands, we routinely used the double mutant (21, 22) -in this study. It must be emphasized that the single 22-mutant gave the same result as the double mutant, whereas the single 21-mutant did not. It can be noted that in the presence of canavanine, 22- mutants did not prevent the formation of giants, but uniformly the giants produced were of the 1.5 to 6 class, including those pairings that normally gave giants of 10 to 14 head lengths (Fig. 4) . We had several pairings at our disposal for the production of giants by canavanine, and all yielded early in the prohead pathway, as is well established, but that it also acts later during DNA packaging. These results prompted us to examine the giants generated by using mutants involved in some aspect of DNA synthesis and packaging (5, 17, 24, 27, 29) , particularly since DNA in giant phage appears to be the result of recombination (18) . Table 2 , footnote c) were the greatest observed for petite production.
As indicated earlier, 17-or 49-mutants coinfected with 24-yield giants in the absence of canavanine. As with the other mixed infections involving 24-mutants, none of these giants was smaller than 7 head lengths, and more than 90% were in the 10 to 14 size range. When canavanine was present, however, the size distribution of giants appeared to be multiphasic (Fig. 5 ) for several such mutants (Table 5) . There appeared to be a repeat unit of about 3.5 head lengths, with successively fewer giants generated at higher multiples of 3.5. Such data are only suggestive, but if we accept the headfull hypothesis (8, 14, 23, 30) , they may imply (ii) Gene 22 product has a regulatory function in determining head length. In the presence of canavanine, all giants from infections using phage defective in gene 22 are in the 2-to 5-head-length class, and no giants are formed in the absence of canavanine. It would be interesting to determine whether the missense mutants of gene 23 (12, 13) or the ts mutants of gene 24 (1, 2) would lead to giants if gene 22 mutants were used to co-infect. Moreover, gene 22 deficiencies can also lead to a high proportion of petites (25; this report).
(iii) Other genes may be influential. We observed that with canavanine-arginine treatment, mixed infection with phage mutant in some aspects of DNA synthesis, repair, or recombination led to a phasing in the size distribution of giants. This may indicate that DNA processing has an effect on the size of the giant prohead. For example, Paulson et al. (25) had difficulty accounting for the results of Chao et al. (6) on the generation of petites in DNAdeficient hosts. A strict adherence to the prohead pathway model (22) does not allow DNA processing to affect head maturation, but, as related earlier, DNA may be associated with proheads containing uncleaved structural proteins (H. Wunderli and E. Kellenberger, personal communication).
From these results, it is difficult to unambiguously determine the nature of the gene product interactions that lead to giants or petites. We have demonstrated that gene 23 and gene 24 mutations have an effect, but whether faulty gene products or diminished amounts of normal gene products are involved is an open question. Certainly, our results demonstrate that not all mixed infections lead to giant formation. Bijlenga et al. (2) reasoned that since so many ts mutants of gene 24 give rise to giants, the only factor common to them must be diminished amounts of active p24. They suggested that p23 might be replacing p24 in the end caps, leading to an abnormal elongation of the prohead. The properties of the bypass 24 mutants certainly show that p24 is dispensable. However, bypass 24 mutants by themselves do not produce giants, suggesting that total replacement of p24 is not the key. In the absence of canavanine, giants were produced by using the 24--bypass 24 mutants only when 23-mutants were used to co-infect. Presumably 23-mutants provided faulty p23 and normal p24, and the normal p24 could interact only with the altered p23 supplied by the bypass 24 mutants. This type of analysis must be tempered by the fact that in every case except the bypass situation, giants were produced in the absence of canavanine only when 24-mutant was one of the coinfecting phage. Here too, any 24-mutant worked, but it is important to point out that the number of giants varied over a 40-fold range. Since both normal p24 and p23 as well as faulty p24 and p23 were present in all these pairings, with or without canavanine, the solution may well turn out to be an interaction of all these products at critical concentrations. Perhaps sodium dodecyl sulfate-gel analysis of different mixed infection products over the range of giant production obtained will reveal important differences and allow a more critical assessment of the results presented here.
